Effect of Intratympanic Dexamethasone in Idiopathic Sudden Sensorineural Hearing Loss | Zendy

Rabi Hembrom | Zendy; Indranil Sen | Zendy; Bina Tamang | Zendy; Satadal Mandal | Zendy; Amit Chakrabarti | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Intratympanic Dexamethasone in Idiopathic Sudden Sensorineural Hearing Loss

Author(s) -

Rabi Hembrom,

Indranil Sen,

Bina Tamang,

Satadal Mandal,

Amit Chakrabarti

Publication year - 2019

Publication title -

bengal journal of otolaryngology and head neck surgery

Language(s) - English

Resource type - Journals

eISSN - 2395-2407

pISSN - 2395-2393

DOI - 10.47210/bjohns.2019.v27i2.240

Subject(s) - medicine , dexamethasone , audiogram , hearing loss , corticosteroid , refractory (planetary science) , audiometry , anesthesia , surgery , audiology , physics , astrobiology

Oral steroids currently represent the standard treatment for idiopathic sudden sensorineural hearing loss The aim of this study is to assess the effectiveness of intratympanic dexamethasone injection for treating ‘Idiopathic sudden sensori-neural hearing loss’ (ISSNHL) not improved with conventional oral steroid. Materials and Methods A prospective study was conducted on 30 patients refractory to oral steroid therapy between June 2017 to May 2018. ‘Intratympanic dexamethasone injection’ (ITDI) was given every week for 3 consecutive weeks. Hearing was assessed by performing pure tone audiogram before every ITDI and also 1 week after the completion of treatment. Results Hearing improvement was found in 19 out of the 30 cases (63.3%). Conclusions Intratympanic dexamethasone significantly improves the prognosis of ISSNHL and is a safe, inexpensive and effective treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research